One institutions’ experience with a true standard 15 mCi dose of I-131 for the treatment of Graves’ disease : Nuclear Medicine Communications

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original article

One institutions’ experience with a true standard 15 mCi dose of I-131 for the treatment of Graves’ disease

Muhleman, Mitchel A.a; Fahim, Alib; Benefield, Thadc; Oldan, Jorge D.a; Khandani, Amir H.a

Author Information
Nuclear Medicine Communications: November 16, 2022 - Volume - Issue - 10.1097/MNM.0000000000001633
doi: 10.1097/MNM.0000000000001633
  • Buy
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.